Cargando…

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections

Guillain-Barré syndrome (GBS) is associated with various types of preceding infections including Campylobacter jejuni and cytomegalovirus, but there is also an association with arthropod borne viruses (arboviruses), such as Zika virus, that are endemic in tropical regions. Here we present the clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Langerak, Thomas, van Rooij, Irene, Doornekamp, Laura, Chandler, Felicity, Baptista, Mark, Yang, Harvey, Koopmans, Marion P. G., GeurtsvanKessel, Corine H., Jacobs, Bart C., Rockx, Barry, Adriani, Kirsten, van Gorp, Eric C. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902883/
https://www.ncbi.nlm.nih.gov/pubmed/33643209
http://dx.doi.org/10.3389/fneur.2021.635753
_version_ 1783654622357880832
author Langerak, Thomas
van Rooij, Irene
Doornekamp, Laura
Chandler, Felicity
Baptista, Mark
Yang, Harvey
Koopmans, Marion P. G.
GeurtsvanKessel, Corine H.
Jacobs, Bart C.
Rockx, Barry
Adriani, Kirsten
van Gorp, Eric C. M.
author_facet Langerak, Thomas
van Rooij, Irene
Doornekamp, Laura
Chandler, Felicity
Baptista, Mark
Yang, Harvey
Koopmans, Marion P. G.
GeurtsvanKessel, Corine H.
Jacobs, Bart C.
Rockx, Barry
Adriani, Kirsten
van Gorp, Eric C. M.
author_sort Langerak, Thomas
collection PubMed
description Guillain-Barré syndrome (GBS) is associated with various types of preceding infections including Campylobacter jejuni and cytomegalovirus, but there is also an association with arthropod borne viruses (arboviruses), such as Zika virus, that are endemic in tropical regions. Here we present the clinical characteristics of 12 GBS patients from Suriname that were hospitalized between the beginning of 2016 and half 2018. Extensive diagnostic testing was performed for pathogens that are commonly associated with GBS, but also for arboviruses, in order to identify the preceding infection that might have led to GBS. With this extensive testing algorithm, we could identify a recent infection in six patients of which four of them had evidence of a recent Zika virus or dengue virus infection. These results suggest that arboviruses, specifically Zika virus but possibly also dengue virus, might be important causative agents of GBS in Suriname. Furthermore, we found that more accessibility of intravenous immunoglobulins or plasma exchange could improve the treatment of GBS in Suriname.
format Online
Article
Text
id pubmed-7902883
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79028832021-02-25 Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections Langerak, Thomas van Rooij, Irene Doornekamp, Laura Chandler, Felicity Baptista, Mark Yang, Harvey Koopmans, Marion P. G. GeurtsvanKessel, Corine H. Jacobs, Bart C. Rockx, Barry Adriani, Kirsten van Gorp, Eric C. M. Front Neurol Neurology Guillain-Barré syndrome (GBS) is associated with various types of preceding infections including Campylobacter jejuni and cytomegalovirus, but there is also an association with arthropod borne viruses (arboviruses), such as Zika virus, that are endemic in tropical regions. Here we present the clinical characteristics of 12 GBS patients from Suriname that were hospitalized between the beginning of 2016 and half 2018. Extensive diagnostic testing was performed for pathogens that are commonly associated with GBS, but also for arboviruses, in order to identify the preceding infection that might have led to GBS. With this extensive testing algorithm, we could identify a recent infection in six patients of which four of them had evidence of a recent Zika virus or dengue virus infection. These results suggest that arboviruses, specifically Zika virus but possibly also dengue virus, might be important causative agents of GBS in Suriname. Furthermore, we found that more accessibility of intravenous immunoglobulins or plasma exchange could improve the treatment of GBS in Suriname. Frontiers Media S.A. 2021-02-10 /pmc/articles/PMC7902883/ /pubmed/33643209 http://dx.doi.org/10.3389/fneur.2021.635753 Text en Copyright © 2021 Langerak, van Rooij, Doornekamp, Chandler, Baptista, Yang, Koopmans, GeurtsvanKessel, Jacobs, Rockx, Adriani and van Gorp. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Langerak, Thomas
van Rooij, Irene
Doornekamp, Laura
Chandler, Felicity
Baptista, Mark
Yang, Harvey
Koopmans, Marion P. G.
GeurtsvanKessel, Corine H.
Jacobs, Bart C.
Rockx, Barry
Adriani, Kirsten
van Gorp, Eric C. M.
Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title_full Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title_fullStr Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title_full_unstemmed Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title_short Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
title_sort guillain-barré syndrome in suriname; clinical presentation and identification of preceding infections
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902883/
https://www.ncbi.nlm.nih.gov/pubmed/33643209
http://dx.doi.org/10.3389/fneur.2021.635753
work_keys_str_mv AT langerakthomas guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT vanrooijirene guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT doornekamplaura guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT chandlerfelicity guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT baptistamark guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT yangharvey guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT koopmansmarionpg guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT geurtsvankesselcorineh guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT jacobsbartc guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT rockxbarry guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT adrianikirsten guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections
AT vangorpericcm guillainbarresyndromeinsurinameclinicalpresentationandidentificationofprecedinginfections